Pall Corporation, a global leader in filtration, separation and purification, today inaugurated its Pall Life Sciences Centre of Excellence in Singapore. Located in Singapore's Gemini Science Park II, Pall's newest Centre of Excellence provides the most advanced process demonstration, validation support and training capabilities available for a growing base of life sciences customers in the region.

"Pall's new Singapore Life Sciences Centre of Excellence is representative of our global strategy of investing in high-growth areas where the demand for biotechnology process development and training is acute. It will serve as a central hub for our business and operational activities across the region," said Yves Baratelli, President, Pall Life Sciences. "This latest Centre of Excellence also reinforces Pall's commitment to providing high-level technical support for local start-ups as well as multinational customers that do business in the area."

"The Singapore Life Sciences Centre of Excellence consolidates training and technical services, making it unparalleled as a resource for biotechnology companies seeking solutions for their process challenges," said Eric Garnier, President, Pall Asia. "Biotechnology drugs and biologically derived vaccines are filtration and purification intensive. Pall is singularly well positioned to meet the growing market demand for this expertise."

"I would like to congratulate Pall on the opening of its new Singapore Life Sciences Centre of Excellence. Leading companies such as Pall play an important role in the development of our biopharmaceutical industry. Pall's decision to set up the Centre here is an example of how companies are capitalizing on the growth opportunities in Asia through Singapore," said Mr. Yeoh Keat Chuan, Assistant Managing Director, Singapore Economic Development Board.